175 related articles for article (PubMed ID: 2160407)
1. Dosimetry and treatment planning in radioimmunotherapy.
Leichner PK; Yang NC; Wessels BW; Hawkins WG; Order SE; Klein JL
Front Radiat Ther Oncol; 1990; 24():109-20; discussion 121-2. PubMed ID: 2160407
[No Abstract] [Full Text] [Related]
2. Phase I-II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies.
Order SE; Klein JL; Ettinger D; Alderson P; Siegelman S; Leichner P
Int J Radiat Oncol Biol Phys; 1980 Jun; 6(6):703-10. PubMed ID: 6256319
[No Abstract] [Full Text] [Related]
3. Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma.
Klein JL; Nguyen TH; Laroque P; Kopher KA; Williams JR; Wessels BW; Dillehay LE; Frincke J; Order SE; Leichner PK
Cancer Res; 1989 Nov; 49(22):6383-9. PubMed ID: 2553255
[TBL] [Abstract][Full Text] [Related]
4. [Effect of radio-immunochemotherapy-using antiferritin antibody combined with anthracycline drugs on hepatocellular carcinoma cell].
Une Y; Sato Y; Alam S; Nagabuchi E; Hata Y; Uchino J
Gan To Kagaku Ryoho; 1993 Jan; 20(1):161-3. PubMed ID: 8380685
[No Abstract] [Full Text] [Related]
5. Regional radioactive treatments for hepatocellular carcinoma.
Gonsalves CF; Brown DB; Carr BI
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):453-6. PubMed ID: 19072393
[No Abstract] [Full Text] [Related]
6. A treatment planning program for radioimmunotherapy.
Macey DJ; DeNardo GL; DeNardo SJ
Front Radiat Ther Oncol; 1990; 24():123-31; discussion 161-5. PubMed ID: 2341047
[No Abstract] [Full Text] [Related]
7. Immunoradiotherapy for primary nonresectable hepatocellular carcinoma.
Sitzmann JV; Order SE
Surg Clin North Am; 1989 Apr; 69(2):393-400. PubMed ID: 2538937
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatoma.
Leichner PK; Yang NC; Frenkel TL; Loudenslager DM; Hawkins WG; Klein JL; Order SE
Int J Radiat Oncol Biol Phys; 1988 May; 14(5):1033-42. PubMed ID: 2834309
[TBL] [Abstract][Full Text] [Related]
9. Invited commentary.
Salem R
J Vasc Interv Radiol; 2011 Oct; 22(10):1362-3. PubMed ID: 21961980
[No Abstract] [Full Text] [Related]
10. Dosimetry of 131I-labeled anti-ferritin in hepatoma: a model for radioimmunoglobulin dosimetry.
Leichner PK; Klein JL; Garrison JB; Jenkins RE; Nickoloff EL; Ettinger DS; Order SE
Int J Radiat Oncol Biol Phys; 1981 Mar; 7(3):323-33. PubMed ID: 6268576
[No Abstract] [Full Text] [Related]
11. [131I antiferritin in the treatment of hepatoma and Hodgkin's disease].
Cohen Y; Moroz H
Harefuah; 1986 Dec; 111(11):398-9. PubMed ID: 3028919
[No Abstract] [Full Text] [Related]
12. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Hellman S
J Clin Oncol; 1985 Dec; 3(12):1569. PubMed ID: 2999345
[No Abstract] [Full Text] [Related]
13. Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?
Bardiès M; Buvat I
Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):5-20. PubMed ID: 21386782
[No Abstract] [Full Text] [Related]
14. [Use of anti-ferritin antibody in the diagnosis and treatment of hepatocellular carcinoma].
Liu KD
Zhonghua Yi Xue Za Zhi; 1987 Nov; 67(11):621. PubMed ID: 2834028
[No Abstract] [Full Text] [Related]
15. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789
[TBL] [Abstract][Full Text] [Related]
16. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
[TBL] [Abstract][Full Text] [Related]
17. Radiographically identified necrosis after 90Y microsphere brachytherapy: a new standard for oncologic response assessment?
Welsh JS
AJR Am J Roentgenol; 2007 Mar; 188(3):765-7. PubMed ID: 17312066
[No Abstract] [Full Text] [Related]
18. Antiferritin immunoglobulin therapy for treatment of hepatoma.
Held J; McLaughlin P
Oncol Nurs Forum; 1987; 14(5):27-31. PubMed ID: 2821514
[No Abstract] [Full Text] [Related]
19. How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide.
Denys A; Pracht M; Duran R; Guiu B; Adib S; Boubaker A; Bize P
Cardiovasc Intervent Radiol; 2015 Aug; 38(4):794-805. PubMed ID: 25828724
[TBL] [Abstract][Full Text] [Related]
20. Model of metastatic growth valuable for radionuclide therapy.
Bernhardt P; Ahlman H; Forssell-Aronsson E
Med Phys; 2003 Dec; 30(12):3227-32. PubMed ID: 14713089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
